Display Settings:

Format

Send to:

Choose Destination
    Gastrointest Endosc Clin N Am. 2010 Jan;20(1):1-10, v.

    Endoluminal therapy for esophageal disease: an introduction.

    Source

    Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. wolfsen.herbert@mayo.edu

    Abstract

    This introductory article summarizes decades of research from many dedicated gastrointestinal endoscopists. It provides a background to Barrett esophagus (BE), exploring the risk of progression to dysplasia and esophageal adenocarcinoma. Two premalignant conditions, BE and colon adenoma, are compared, including their progression to esophageal adenocarcinoma and colon and rectal carcinoma, respectively. A comparison of the risks of surgical treatment and post-surgical complications of these cancers and of the strikingly different paradigms for their prevention is presented. The article concludes with the rationale for endoscopic treatment of Barrett disease.

    PMID:
    19951790
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk